⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29571 | 1.00 | — | — | |
| SCHEMBL3516924 | 1.00 | — | — | |
| SCHEMBL371416 | 1.00 | — | — | |
| SCHEMBL28669 | 0.82 | — | — | |
| SCHEMBL28771 | 0.82 | — | — | |
| SCHEMBL29450 | 0.82 | — | — | |
| SCHEMBL1501859 | 0.82 | — | — | |
| SCHEMBL29413 | 0.82 | — | — | |
| SCHEMBL29288 | 0.82 | — | — | |
| SCHEMBL1133698 | 0.82 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 516 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024126654-A1 | ANTISENSE OLIGONUCLEOTIDES TARGETING ACTL6B | F. HOFFMANN-LA ROCHE AG (CH) | 2024-06-20 | — | — | WO | claimed |
| WO-2024046937-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-03-07 | — | — | WO | claimed |
| WO-2023175091-A2 | MAPT siRNA AND USES THEREOF | JANSSEN PHARMACEUTICA NV (BE) | 2023-09-21 | — | — | WO | claimed |
| WO-2023117738-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2023-06-29 | — | — | WO | claimed |
| WO-2020101880-A1 | COMPOSITIONS AND METHODS OF TREATING SYSTEMIC LUPUS ERYTHEMATOSUS | OKLAHOMA MEDICAL RESEARCH FOUNDATION (US) | 2020-05-22 | — | — | WO | claimed |
| US-7465734-B2 | Methods and compositions for overcoming resistance to biologic and chemotherapy | CELMED ONCOLOGY (USA), INC. (CA) | 2008-12-16 | — | — | US | claimed |
| WO-2008022469-A1 | 2'-DEOXY-2'-FLUORO-β-D-ARABINONUCLEOSIDE 5'-TRIPHOSPHATES AND THEIR USE IN ENZYMATIC NUCLEIC ACID SYNTHESIS | MCGILL UNIVERSITY (CA) | 2008-02-28 | — | — | WO | claimed |
| CN-118339293-A | 5' -UTR with improved translational efficiency, synthetic nucleic acid molecules comprising same, and vaccine or therapeutic composition comprising same | 财团法人牧岩生命科学研究所 | 2024-07-12 | — | — | CN | disclosed |
| EP-4363572-A1 | METHOD FOR SYNTHESIS OF LINKAGE MODIFIED OLIGOMERIC COMPOUNDS | Ionis Pharmaceuticals, Inc. (US) | 2024-05-08 | — | — | EP | disclosed |
| WO-2024073732-A1 | MODIFIED DOUBLE-STRANDED RNA AGENTS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2024-04-04 | — | — | WO | disclosed |
| WO-2024064803-A2 | TENSION-ACTIVATED CELL TAGGING (TACT) | EMORY UNIVERSITY (US) | 2024-03-28 | — | — | WO | disclosed |
| WO-2024052379-A1 | THERAPEUTIC AGENTS FOR METABOLISM-ASSOCIATED DISEASES | UNITED KINGDOM RESEARCH AND INNOVATION (GB) | 2024-03-14 | — | — | WO | disclosed |
| WO-2024046937-A1 | THREOSE NUCLEIC ACID ANTISENSE OLIGONUCLEOTIDES AND METHODS THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2024-03-07 | — | — | WO | disclosed |
| WO-1999008110-A1 | METHODS AND COMPOSITIONS FOR OVERCOMING RESISTANCE TO BIOLOGIC AND CHEMOTHERAPY | NEWBIOTICS, INC. (US) | 1999-02-18 | — | — | WO | disclosed |
| WO-1999006424-A1 | LYXOFURANOSYL BENZIMIDAZOLES AS ANTIVIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1999-02-11 | — | — | WO | disclosed |
| US-5840743-A | TREATING HERPES VIRUS, CYTOMEGALO VIRUS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1998-11-24 | — | — | US | disclosed |
| WO-1998040390-A2 | OLIGOSACCHARIDES AND THE DERIVATIVES THEREOF, CHEMO-ENZYMATIC METHOD FOR THE PRODUCTION THEREOF | BAYER AKTIENGESELLSCHAFT (DE) | 1998-09-17 | — | — | WO | disclosed |
| EP-0832898-A2 | Substituted amino acid derivatives | BAYER AG (DE) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997027204-A1 | MODIFIED BENZIMIDAZOLE NUCLEOSIDES AS ANTIVIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1997-07-31 | — | — | WO | disclosed |
| WO-1997027205-A1 | IMIDAZO[1,2-A]PYRIDINE C-NUCLEOSIDES AS ANTIVIRAL AGENTS | THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 1997-07-31 | — | — | WO | disclosed |